Home – US – Neurescue

Saving Hearts and Minds

The first computer-aided aortic occlusion catheter, with intelligent safety feedback and pressure-limited filling.

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)

REBOA is a technique where a balloon is advanced into the descending aorta through the femoral artery and temporarily inflated, thereby redirecting flow to the central circulation.

The NEURESCUE device

safeREBOA

The NEURESCUE device is the first computer-aided aortic occlusion catheter, with intelligent safety feedback and pressure-limited filling. The device is designed with as few user steps as possible, built-in feedback and a high safety profile. These elements are crucial for the time-sensitive situations surrounding the use of REBOA. Several preclinical and clinical investigations have been published, describing procedures that involve aortic occlusion, most of them in time-limited emergency settings [1]. Our future goal is to enable the clinical utility of further intelligent procedures.

Positioning safety feedback

The computer-assisted safety feedback includes an alarm indicating if insertion into branch vessels to the aorta has occurred.

Pressure safety by design

Our proprietary pressure-limited filling protects against over-inflation, rupture and unintended pressure from the balloon.

Automated filling and deflation

No estimation or second-guessing. NEURESCUE’s automated filling and deflation ensure a secure and soft occlusion based on objective criteria from beginning to end of the procedure.

Designed for emergency use

With a portable package and a minimal number of user steps to a successful occlusion, the NEURESCUE device is designed for the emergency setting.

We are continuously looking for strategic and clinical partners.

Neurescue Management

Management

HABIB FROST, M.D CHIEF EXECUTIVE OFFICER
BJØRN BROBY GLAVIND BUSINESS DEVELOPMENT DIRECTOR
Anette Kristiansen Clinical Director
Olof Huldt Director of R&D

Board of Directors

Habib Frost, M.D. MEMBER OF THE BOARD
Jeppe Øvlesen Chairman
Helene Quie MEMBER OF THE BOARD
BENT JOHNSEN MEMBER OF THE BOARD
FLEMMING MØLLER MEMBER OF THE BOARD

In The Press

References & Terms of Use

The Neurescue device is not yet FDA cleared and not available for sale.

[1] Borger van der Burg BLS et al. A systematic review and meta-analysis of the use of resuscitative endovascular balloon occlusion of the aorta in the management of major exsanguination. Eur J Trauma Emerg Surg. 2018 Aug;44(4):535-550.

Disclaimer & Terms of Use